Paper7201356
Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma.
Meijer S and 6 others. Cancer Chemother Pharmacol, 1982. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma. Papers, record 7201356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7201356
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nephrotoxicity of cis-diamminedichloride platinum (CDDP) during remission-induction and maintenance chemotherapy of testicular carcinoma.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Kidney | Major topic |
| Testicular Neoplasms | Major topic |
| Adult | |
| Glomerular Filtration Rate | |
| Humans | |
| Male | |
| Renal Circulation |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4126381 | Clinical trials of cis-diamminedichloroplatinum (NSC-119875). | Cancer Chemother Rep | 1973 | https://conductscience.org/library/papers/4126381 | PubMed |
| 2 | 4349972 | Uranyl nitrate induced acute renal failure in the rat: effect of varying doses and saline loading. | Proc Soc Exp Biol Med | 1973 | https://conductscience.org/library/papers/4349972 | PubMed |
| 3 | 4856724 | Diaminodichloroplatinum: a phase I study showing responses in testicular and other tumors. | Cancer | 1974 | https://conductscience.org/library/papers/4856724 | PubMed |
| 4 | 5383719 | Mercuric chloride-induced renal failure and intrarenal distribution of blood flow. | Acta Physiol Acad Sci Hung | 1969 | https://conductscience.org/library/papers/5383719 | PubMed |
| 5 | 882199 | A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. | Neth J Med | 1977 | https://conductscience.org/library/papers/882199 | PubMed |
| 6 | 71004 | Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. | Ann Intern Med | 1977 | https://conductscience.org/library/papers/71004 | PubMed |
| 7 | 5084882 | Experimental acute renal failure induced by uranyl nitrate in the dog. | Circ Res | 1972 | https://conductscience.org/library/papers/5084882 | PubMed |
| 8 | 87614 | Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma. | Lancet | 1979 | https://conductscience.org/library/papers/87614 | PubMed |
| 9 | 638991 | Long term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. | Cancer | 1978 | https://conductscience.org/library/papers/638991 | PubMed |
| 10 | 4910548 | Acute renal failure due to nephrotoxins. | N Engl J Med | 1970 | https://conductscience.org/library/papers/4910548 | PubMed |
| 11 | 1106849 | Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies. | Cancer Chemother Rep | 1975 | https://conductscience.org/library/papers/1106849 | PubMed |
| 12 | 415836 | Nephrotoxicity of cis-platinum (II) dichlorodiammine. | Clin Pharmacol Ther | 1978 | https://conductscience.org/library/papers/415836 | PubMed |
| 13 | 4515709 | Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). | Cancer Res | 1973 | https://conductscience.org/library/papers/4515709 | PubMed |
| 14 | 851939 | The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. | Cancer | 1977 | https://conductscience.org/library/papers/851939 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35107130 | Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans. | Dis Model Mech | 2022 | https://conductscience.org/library/papers/35107130 | PubMed |
| 32276560 | Role of SLC transporters in toxicity induced by anticancer drugs. | Expert Opin Drug Metab Toxicol | 2020 | https://conductscience.org/library/papers/32276560 | PubMed |
| 23300573 | Histological changes in kidney and liver of rats due to gold (III) compound [Au(en)Cl(2)]Cl. | PLoS One | 2012 | https://conductscience.org/library/papers/23300573 | PubMed |
| 6683771 | [The iodine 131-hippurate clearance for the determination of the nephrotoxic effect of cis-dichlorodiamino-platin (II) (cis-platin, cis-DDP)]. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6683771 | PubMed |
| 6537801 | Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6537801 | PubMed |
| 3909096 | Cisplatin: a review of clinical applications and renal toxicity. | Pharm Weekbl Sci | 1985 | https://conductscience.org/library/papers/3909096 | PubMed |
| 2875808 | Cumulative renal tubular damage associated with cisplatin nephrotoxicity. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/2875808 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7201356
GET https://conductscience.org/api/papers/v1/7201356/authors